Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs

Analyst UpgradesNov 20 13:26 ET

Viking Therapeutics Is More Than Just a Weight-loss Stock, and That's Drawing Cheers

MarketWatchNov 20 12:06 ET

Express News | Viking Therapeutics Shares Rise 4.6% Premarket After Co Presents Detailed Mid-Stage Data for Experimental Liver Disease Drug

ReutersNov 20 05:06 ET

Trending Stocks Today | Tonix Pharmaceuticals Surges 58.63% Post-Market

Moomoo NewsNov 19 18:00 ET

Viking Therapeutics Phase 2b Trial Into Non-Alcoholic Steatohepatitis Meets Primary, Secondary Endpoints

MT NewswiresNov 19 16:51 ET

Express News | Viking Therapeutics Presents Results From Phase 2B Voyage Study of Vk2809 in Biopsy-Confirmed Nash/Mash at the 75TH Liver Meeting® 2024

ReutersNov 19 16:03 ET